Key Takeaways
- Approximately 2.4% of the U.S. population meets criteria for body dysmorphic disorder (BDD) in their lifetime
- BDD has a 12-month prevalence rate of 1.7% to 2.9% among adults in community samples
- In adolescents, the point prevalence of BDD is estimated at 1.9% to 2.2%
- Preoccupation with imagined defects is the hallmark symptom, present in 100% of cases by definition
- Repetitive behaviors such as mirror checking occur in 90% of BDD patients
- Excessive grooming rituals reported by 82% of individuals with BDD
- Social anxiety disorder comorbid in 37% of BDD patients
- Major depressive disorder present in 57-76% of BDD cases
- Obsessive-compulsive disorder comorbidity rate of 30-37%
- Selective serotonin reuptake inhibitors (SSRIs) effective in 50-70% of BDD patients at high doses
- Cognitive behavioral therapy (CBT) response rates of 50-70% in randomized trials for BDD
- Combination CBT + SSRI superior to monotherapy, with 80% improvement rates
- With treatment, 40-60% achieve remission within 2 years
- Untreated BDD leads to chronicity in 85% of cases over 5 years
- Suicide risk 45 times higher than general population in BDD
BDD is a surprisingly common yet severely distressing mental health condition.
Comorbidities
Comorbidities Interpretation
Prevalence
Prevalence Interpretation
Prognosis
Prognosis Interpretation
Symptoms
Symptoms Interpretation
Treatment
Treatment Interpretation
Sources & References
- Reference 1NCBIncbi.nlm.nih.govVisit source
- Reference 2JAMANETWORKjamanetwork.comVisit source
- Reference 3SCIENCEDIRECTsciencedirect.comVisit source
- Reference 4PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 5JAADjaad.orgVisit source
- Reference 6JOURNALSjournals.lww.comVisit source
- Reference 7BJGPbjgp.orgVisit source
- Reference 8PSYCHIATRYpsychiatry.orgVisit source
- Reference 9AJPajp.psychiatryonline.orgVisit source






